⌘K

Login Start Free

Home/Filings/4/0001179110-10-012216

4//SEC Filing

KOENIG DAVID 4

Accession 0001179110-10-012216

CIK 0001222244other

View on SEC.gov Company Profile

Filed

Aug 3, 8:00 PM ET

Accepted

Aug 4, 3:03 PM ET

Size

22.5 KB

Accession

0001179110-10-012216

Insider Transaction Report

Form 4

Period: 2010-08-02

ProUroCare Medical Inc.PUMD

Director

Transactions

Purchase
Warrants
2010-08-02+32,475→ 50,000 total
Exercise: $1.30Exp: 2014-01-07→ Common stock, $0.00001 par value (17,525 underlying)
Award
Warrants
2010-08-02+50,000→ 50,000 total
Exercise: $1.30Exp: 2013-08-02→ Common stock, $0.00001 par value (0 underlying)
Exercise of In-Money
Common stock, $0.00001 par value
2010-08-02$1.30/sh+50,000$65,000→ 131,852 total
Sale
Warrants
2010-08-02−32,475→ 0 total
Exercise: $1.30Exp: 2013-07-12→ Common stock, $0.0001 par value (32,475 underlying)
Exercise of In-Money
Warrants
2010-08-02−50,000→ 0 total
Exercise: $1.30Exp: 2014-01-07→ Common stock, $0.00001 par value (50,000 underlying)
Sale
Warrants
2010-08-02−17,525→ 32,475 total
Exercise: $1.30Exp: 2013-07-12→ Common stock, $0.00001 par value (50,000 underlying)
Purchase
Warrants
2010-08-02+17,525→ 17,525 total
Exercise: $1.30Exp: 2014-01-07→ Common stock, $0.00001 par value (0 underlying)

Holdings

Common Stock, $0.00001 par value
(indirect: Shares held by Clinical Network Management Corp., of which reporting person is a managing officer.)
1,875
Stock Options
Exercise: $11.33Exp: 2012-04-19→ Common Stock, $0.00001 par value (3,000 underlying)
3,000
Stock options
Exercise: $1.50Exp: 2016-09-29→ Common stock, $0.00001 par value (50,000 underlying)
50,000
Common Stock, $0.00001 par value
(indirect: Shares held by Clinical Network Inc., of which the reporting person is a managing officer.)
26,571

Footnotes (4)

[F1]Currently exercisable.
[F2]Options shall vest on the latter of the date that the Company is cleared by the FDA to sell the ProUroScan System in the United States or the date the Company closes on an aggregate of $2,000,000 or more of incremental equity financing after the date of grant(including the exercise of existing warrants).
[F3]On August 2, 2010, the reporting person exchanged 32,475 warrants expiring on July 12, 2013 to an individual for 32,475 warrants expiring on Jaunary 7, 2014. On the same date, the reporting person exchanged 17,525 warrants expiring on July 12, 2013 to another individual for 17,525 warrants expiring on January 7, 2014.
[F4]On August 2, 2010, reporting person exercised 50,000 warrants pursuant to the Issuer's warrant tender offer, paying the $65,000 exercise price by canceling a $65,000 promissory note from the Issuer. Under the terms of the tender offer, holders received, in addition to the common stock purchased, an equal number of new three-year $1.30 common stock purchase warrants.

Documents

1 file

4
edgar.xmlPrimary
FORM 4 -

Issuer

ProUroCare Medical Inc.

CIK 0001222244

Entity typeother

Related Parties

1

filerCIK 0001285927

Filing Metadata

Form type: 4
Filed: Aug 3, 8:00 PM ET
Accepted: Aug 4, 3:03 PM ET
Size: 22.5 KB

View on SEC.gov